Adlai Nortye Ltd. (ANL) — Stock Score Summary

Adlai Nortye Ltd. (ANL) has a MoatMap StockRank of 43/100 based on Quality (14/100), Value (48/100), and Momentum (68/100) factor scores. The current signal is HOLD. Early-stage biotech company with high cash burn and binary clinical trial risks. Completely outside our quality compounder mandate.

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for cancer. The company's competitive edge lies in its proprietary drug candidates targeting immune checkpoints and other novel pathways in oncology, aiming to address unmet medical needs. It operates as a niche player within the highly specialized field of cancer therapeutics, leveraging its R&D capabilities.

Key Financial Metrics

Price$10.84
Market Cap$728M
P/E (Forward)-27.85
Price/Book-52.88
Return on Equity-414.0%
Gross Margin100.0%
Operating Margin-330.5%
Revenue Growth178.1%
Free Cash Flow$-38M

Adlai Nortye Ltd. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Adlai Nortye Ltd.’s (ANL) StockRank?
MoatMap’s StockRank for Adlai Nortye Ltd. (ANL) is 43/100, with a Hold signal. It is a composite of Quality (14), Value (48), and Momentum (68) factor ranks across MoatMap’s 19,000+ stock universe.
Does Adlai Nortye Ltd. have an economic moat?
Adlai Nortye Ltd. (ANL) has a Quality factor score of 14/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Adlai Nortye Ltd. a buy, hold, or sell?
MoatMap’s current signal for Adlai Nortye Ltd. (ANL) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Adlai Nortye Ltd. in?
Adlai Nortye Ltd. (ANL) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksANL deep dive reportAI ChampionsHow we score stocksSense-check another stock